Arbutus Biopharma Corp to Discuss the New Data Being Presented at EASL - Conference Call Transcript
Good morning, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation EASL 2021 presentation review conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Ms. Pam Murphy. Please go ahead.
Thank you, and good morning. Hopefully, everyone has been able to connect to EASL presentation review webcast and you're able to access the slides. The slides are also available in PDF form under the Investors section of Arbutus' website at www.arbutusbio.com.
With me today from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; Dr. Gaston Picchio, Chief Development Officer; Dr. Micheal Sofia, Chief Scientific Officer; and Dave Hastings, Chief Financial Officer.
Bill will begin with a quick summary of the EASL presentation followed by Gaston, who will then walk you through the highlights of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
